文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Immune profiles of a COVID-19 adolescent with mild symptoms and anti-viral antibody deficiency.

作者信息

Lai Yang-Dian, Chen Ying-Ying, Sun Ji-Ping, Ling Yun, Xu Jie, Ye Youqiong, Shen Lei, Lu Hong-Zhou, Su Bing, Wang Ying

机构信息

Shanghai Institute of Immunology, Department of Immunology and Microbiology, and the Ministry of Education Key Laboratory of Cell Death and Differentiation, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Department of Infectious Disease, Shanghai Public Health Clinical Center, Shanghai, 201052, China.

出版信息

Fundam Res. 2021 Mar;1(2):117-123. doi: 10.1016/j.fmre.2021.02.004. Epub 2021 Feb 17.

DOI:10.1016/j.fmre.2021.02.004
PMID:40477411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7889007/
Abstract
摘要

相似文献

[1]
Immune profiles of a COVID-19 adolescent with mild symptoms and anti-viral antibody deficiency.

Fundam Res. 2021-3

[2]
Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.

mSphere. 2020-11-11

[3]
Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations (Archived)

2025-1

[4]
Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.

Front Immunol. 2021

[5]
Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency.

J Clin Immunol. 2022-8

[6]
Comparative Analysis of Antimicrobial Antibodies between Mild and Severe COVID-19.

Microbiol Spectr. 2023-8-17

[7]
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.

Front Immunol. 2022

[8]
SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy.

J Clin Invest. 2020-10-1

[9]
Anti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence.

Rev Soc Bras Med Trop. 2022

[10]
Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency.

J Clin Immunol. 2022-2

本文引用的文献

[1]
Dynamic anti-spike protein antibody profiles in COVID-19 patients.

Int J Infect Dis. 2021-2

[2]
Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays.

Cell Discov. 2020-10-27

[3]
COVID-19 diagnosis -A review of current methods.

Biosens Bioelectron. 2021-1-15

[4]
Computational Immune Proteomics Approach to Target COVID-19.

J Proteome Res. 2020-9-23

[5]
Humoral Immune Response to SARS-CoV-2 in Iceland.

N Engl J Med. 2020-9-1

[6]
Single-cell landscape of immunological responses in patients with COVID-19.

Nat Immunol. 2020-8-12

[7]
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm.

Nat Commun. 2020-8-6

[8]
Detection of COVID-19: A review of the current literature and future perspectives.

Biosens Bioelectron. 2020-7-21

[9]
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

Nature. 2020-7-15

[10]
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.

Science. 2020-6-22

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索